Nkechi Azie, MD MBA

Highly accomplished Biopharma Chief Medical Officer with 20+ years of global leadership specializing in strategic pipeline acceleration to meet projected product positioning, applied clinical pharmacology, in infectious disease /Rare disease drug development. Expert in bridging translational science with commercial reality from phase 1-4, having advanced multiple assets through successful IND, NDA, and sNDA approvals across the US, Europe, and Asia. A builder of high-performance teams and built critical corporate functions from the ground up, with a proven track record of leading 5 global product launches. Combining triple board certifications with a Notre Dame Executive MBA (Cum Laude), delivers the rigorous scientific due diligence, portfolio strategy, and investor-facing communication required to scale early-stage biotech companies to clinical proof-of-concept.